Published in Biotech Business Week, May 23rd, 2011
According to Grace Colon, PhD, President of Intrexon's Industrial Products Division, Intrexon will be deploying Novici's GRAMMR® technology toward a spectrum of industrial applications in concert with Intrexon's UltraVector® platform and extensive library of modular DNA control components. "Gene shuffling has been one of the cornerstone genetic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.